Snapshot of the 2026 Speaker Faculty Top Takeaways: Unlocked the next generation of GLP-1 combinations and gained competitive intelligence on multi-agonist and combination therapies designed to enhance efficacy, minimize muscle loss, and improve body composition for superior patient outcomes Discovered high-value indication expansion and explored the next frontier of GLP-1 development beyond obesity through exclusive data on clinical programs targeting liver, renal and cardiometabolic disorders alongside neurological diseases and womens health conditions Mastered alternative delivery and patient adherence through dedicated sessions focused on overcoming the challenges of administration through oral programs and less frequent dosing strategies for long-term patient success Benchmarked against industry titans and innovators and heard directly from the companies leading the pipeline, including experts from Eli Lilly , Constructive Bio and Regeneron
FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or any other pharmaceutical manufacturer mentioned in this article
The moment a patient hits a dose that causes troublesome nausea or loss of appetite beyond whats manageable, Nooms clinician-designed protocol holds at that dose longer, or even dials back to the prior dose until symptoms subside
The more you practice safe, comfortable injections, the more natural it will feel
The supplement's rise reflects a broader cultural obsession with achieving a specific body image
For a juice guy to take fruits, make juice and then ferment it, its like I made a mistake, Langer said
